HCAT
Health Catalyst, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$1.71
−0.87%Year over year
Reported trailing growth
- Revenue
- -7.5%
- EBITDA
- —
- EBIT
- +35.0%
- EPS
- —
- Free cash flow
- +183.1%
- Operating cash flow
- +567.8%
Forward estimates
Based on analyst estimates
- Revenue
- -29.3%
- EBITDA
- +129.6%
- EPS
- +99.9%
Three-year CAGR
- Revenue
- +4.0%
- EBITDA
- —
- EBIT
- +48.3%
- Net income
- —
- EPS
- —
- Free cash flow
- +87.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026